FDA approves Alexion Pharma's enzyme-replacement therapy

(Reuters) - The U.S. Food and Drug Administration on Tuesday approved Alexion Pharmaceutical Inc's treatment for a rare and potentially fatal genetic disorder.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro